跳至主要内容
临床试验/NCT02173743
NCT02173743已完成不适用

Calcific Tendinitis of the Rotator Cuff: a Randomized Controlled Trial to the Effects of the Adjuvant Application of Platelet-rich Plasma After Needle Aspiration of Calcific Deposits

Orthopedisch Centrum Oost Nederland2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2014年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80
试验地点
2
主要终点
Numeric Rating Scale (NRS) pain

研究概览

简要总结

Needle aspiration of calcific deposits (NACD ) is the treatment of choice for calcific tendinitis which does not respond to conservative treatment. NACD is effective in approximately 70% of the patients.When NACD is not effective, surgery is often the only treatment that remains.Surgery, however, is discouraged by th e Dutch guidelines for diagnosing and treating patients with subacromial pain syndrome.Therefore,both patients and the doctors treating those patients will benefit from a more effective minimal invasive treatment for calcific tendinitis.Injection of platelet-rich plasma (PRP) might, considering its positive effect on tissue repair, be a possible solution here.Previous research investigating the effects of PRP on other tendinopathies did, however, show controversial results. The aim of this double-blind randomized controlled trial is to investigate the effect of the adjuvant application of PRP after NACD on pain reduction ,recovery of shoulder function, tendon recovery,resorption of calcific deposits, the percentage of patients with persistent complaints and quality of life.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • age > 18 yrs
  • clinical manifestions of tendinitis calcarea (pain, stifness, lock sensations, muscle atrophy)
  • persistent pain sympoms >6 months
  • standardized AP x-ray shows calcific deposit of > 5mm & morphologic Type I & II deposits (classification of Gärtner en Simons)
  • ineffective intervention > 2 types of conservative treatment (among which are non-steroidal anti-inflammatory drugs, physiotherapy, local anesthesia injection and/or corticosteroids, extracorporele shock wave therapy)
  • indication and referral for barbotage by orthopeadic surgeon

排除标准

  • age > 55 years
  • morphological type III deposits according to classification of Gärtner and Simons) (as indicated by standardized x-ray AP)
  • bigliani type III acromion, and acromial spur of acromioclavicular osteovyt
  • previous (ineffective) barbotage
  • the existence of other shoulder related injuries next to calcific tendinitis (full-thickness rupture of the rotator cuff, adhesive capsulitis (frozen shoulder), arthrosis of the glenohumeral- or acromioclavicalar joint
  • shoulder joint instability
  • shoulder injury due to trauma or previous shoulder surgeries
  • other types of disorders that could negatively influence the outcomes (rheumatic arthritis. cervical spine disorders, neurological upper extremity disorders, diabetes mellitus, infections, blood disorders, malignity, pregnancy)
  • known allergic responses to one of the medications applied in the current study (lidocaine, bupivacaine, kenacort)
  • usage of anti-coagulants other than ascal of plavix

研究组 & 干预措施

Control group

Other

Regular barbotage

干预措施: Control (Other)

PRP group

Experimental

PRP during barbotage

干预措施: PRP (Other)

结局指标

主要结局

Numeric Rating Scale (NRS) pain

时间窗: 6 months post barbotage

Score to assess the amount of pain

次要结局

  • Constant-Murley Score (CMS)(6 weeks, 3 - 6- 12- 25 months post barbatoge)
  • Quality of Life (EQ-5D)(6 weeks, 3- 6- 12- 24 months post barbotage)

研究者

发起方
Orthopedisch Centrum Oost Nederland
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验